138 related articles for article (PubMed ID: 36480302)
1. Combined Detection of Islet Autoantibodies for Clinical Diagnosis of Type 1 Diabetes in the Low-Prevalence Population.
Qi Y; Chen S; Chen H; Chen Y; Shi Y; Qin Y; Zhang M; Yang T; Gu Y
J Clin Endocrinol Metab; 2023 May; 108(6):e326-e333. PubMed ID: 36480302
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Multiplex Electrochemiluminescence Assay Applicable to General Population Screening for Type 1 Diabetes and Celiac Disease.
He L; Jia X; Rasmussen CG; Waugh K; Miao D; Dong F; Frohnert B; Steck AK; Simmons KM; Rewers M; Yu L
Diabetes Technol Ther; 2022 Jul; 24(7):502-509. PubMed ID: 35238620
[No Abstract] [Full Text] [Related]
3. Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
Gu Y; Jia X; Vartak T; Miao D; Dong F; Jerram ST; Rewers M; Ferrara A; Lawrence JM; Yu L; Leslie RD;
Diabetologia; 2021 Sep; 64(9):2052-2060. PubMed ID: 34272582
[TBL] [Abstract][Full Text] [Related]
4. Islet autoantibodies in disease prediction and pathogenesis.
Jia X; Gu Y; High H; Yu L
Diabetol Int; 2020 Jan; 11(1):6-10. PubMed ID: 31949998
[TBL] [Abstract][Full Text] [Related]
5. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
[TBL] [Abstract][Full Text] [Related]
6. High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously.
Gu Y; Zhao Z; Waugh K; Miao D; Jia X; Cheng J; Michels A; Rewers M; Yang T; Yu L
EBioMedicine; 2019 Sep; 47():365-372. PubMed ID: 31447394
[TBL] [Abstract][Full Text] [Related]
7. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
[TBL] [Abstract][Full Text] [Related]
8. A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases.
Jia X; He L; Gu Y; High H; Yu L
J Vis Exp; 2020 May; (159):. PubMed ID: 32538917
[TBL] [Abstract][Full Text] [Related]
9. T1D Autoantibodies: room for improvement?
Yu L; Zhao Z; Steck AK
Curr Opin Endocrinol Diabetes Obes; 2017 Aug; 24(4):285-291. PubMed ID: 28509692
[TBL] [Abstract][Full Text] [Related]
10. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
[TBL] [Abstract][Full Text] [Related]
11. Effective assay technologies fit for large-scale population screening of type 1 diabetes.
Jia X; Yu L
Front Clin Diabetes Healthc; 2022; 3():1034698. PubMed ID: 36992730
[TBL] [Abstract][Full Text] [Related]
12. Establishing reference intervals for islet autoantibodies in Han Chinese type 1 diabetes.
Fu Y; Zhang C; Gu Y; Ge S; Li J; Feng J; Zhang L; Liu W; Chen H
Scand J Clin Lab Invest; 2021 Dec; 81(8):641-648. PubMed ID: 34779329
[TBL] [Abstract][Full Text] [Related]
13. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014
[TBL] [Abstract][Full Text] [Related]
14. A High-throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19.
Jia X; He L; Miao D; Zhang C; Rewers M; Yu L
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35876559
[TBL] [Abstract][Full Text] [Related]
15. A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease.
Zhao Z; Miao D; Michels A; Steck A; Dong F; Rewers M; Yu L
J Immunol Methods; 2016 Mar; 430():28-32. PubMed ID: 26809048
[TBL] [Abstract][Full Text] [Related]
16. GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes.
Miao D; Guyer KM; Dong F; Jiang L; Steck AK; Rewers M; Eisenbarth GS; Yu L
Diabetes; 2013 Dec; 62(12):4174-8. PubMed ID: 23974918
[TBL] [Abstract][Full Text] [Related]
17. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status.
Lo B; Swafford AD; Shafer-Weaver KA; Jerome LF; Rakhlin L; Mathern DR; Callahan CA; Jiang P; Davison LJ; Stevens HE; Lucas CL; White J; von Borstel R; Todd JA; Lenardo MJ
J Transl Med; 2011 Nov; 9():203. PubMed ID: 22123298
[TBL] [Abstract][Full Text] [Related]
19. Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
Simmons KM; Fouts A; Pyle L; Clark P; Dong F; Yu L; Usmani-Brown S; Gottlieb P; Herold KC; Steck AK;
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398795
[TBL] [Abstract][Full Text] [Related]
20. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
